Ma B - Search Results

1

Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.

Qu N, Chen D, Ma B, Zhang L, Wang Q, Wang Y, Wang H, Ni Z, Wang W, Liao T, Xiang J, Wang Y, Jin S, Xue D, Wu W, Wang Y, Ji Q, He H, Piao HL, Shi R. Qu N, et al. Among authors: ma b. Nat Commun. 2024 Apr 12;15(1):3175. doi: 10.1038/s41467-024-47581-1. Nat Commun. 2024. PMID: 38609408 Free PMC article.

2

Reduced USP39 expression inhibits malignant proliferation of medullary thyroid carcinoma in vitro.

An Y, Yang S, Guo K, Ma B, Wang Y. An Y, et al. Among authors: ma b. World J Surg Oncol. 2015 Aug 25;13(1):255. doi: 10.1186/s12957-015-0669-4. World J Surg Oncol. 2015. PMID: 26303214 Free PMC article.

3

The Prediction of Sonographic features and BRAF Mutation for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Reply.

Qu N, Shi RL, Ma B, Gao Y, Wang Y, Ji QH. Qu N, et al. Among authors: ma b. World J Surg. 2016 Mar;40(3):761-3. doi: 10.1007/s00268-015-3285-0. World J Surg. 2016. PMID: 26493695 No abstract available.

4

Relationship of body mass index with BRAF (V600E) mutation in papillary thyroid cancer.

Shi RL, Qu N, Liao T, Wei WJ, Lu ZW, Ma B, Wang YL, Ji QH. Shi RL, et al. Among authors: ma b. Tumour Biol. 2016 Jun;37(6):8383-90. doi: 10.1007/s13277-015-4718-y. Epub 2016 Jan 5. Tumour Biol. 2016. PMID: 26733165

5

Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.

Ma B, Wang Y, Yang S, Ji Q. Ma B, et al. Int J Surg. 2016 Apr;28:153-61. doi: 10.1016/j.ijsu.2016.02.093. Epub 2016 Mar 2. Int J Surg. 2016. PMID: 26944586 Free article. Review.

6

DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer.

Ma B, Shi R, Yang S, Zhou L, Qu N, Liao T, Wang Y, Wang Y, Ji Q. Ma B, et al. Onco Targets Ther. 2016 Apr 15;9:2255-63. doi: 10.2147/OTT.S103554. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143921 Free PMC article.

7

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.

Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM, Xiang J, Lu ZW, Zhu YX, Li DS, Ji QH. Liao T, et al. Among authors: ma b. Oncotarget. 2017 Jan 3;8(1):238-247. doi: 10.18632/oncotarget.10825. Oncotarget. 2017. PMID: 27462868 Free PMC article.

8

Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model.

Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH. Shi RL, et al. Among authors: ma b. Onco Targets Ther. 2016 Aug 12;9:5015-22. doi: 10.2147/OTT.S107187. eCollection 2016. Onco Targets Ther. 2016. PMID: 27574443 Free PMC article.

9

Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.

Ma B, Liao T, Wen D, Dong C, Zhou L, Yang S, Wang Y, Ji Q. Ma B, et al. Sci Rep. 2016 Nov 11;6:36973. doi: 10.1038/srep36973. Sci Rep. 2016. PMID: 27833134 Free PMC article.

10

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.

Yang S, Ji Q, Chang B, Wang Y, Zhu Y, Li D, Huang C, Wang Y, Sun G, Zhang L, Guan Q, Xiang J, Wei W, Lu Z, Liao T, Meng J, Wang Z, Ma B, Zhou L, Wang Y, Yang G. Yang S, et al. Among authors: ma b. Oncotarget. 2017 Jan 24;8(4):5976-5991. doi: 10.18632/oncotarget.13355. Oncotarget. 2017. PMID: 27863406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,636 results

Search Page

Filters